Laboratory Animal Diets: The Pandemic's Impact, Diverse Applications and End Users

How Has The Pandemic Impacted This Particular Market Segment?

The COVID-19 pandemic has certainly left its mark on various economic sectors, and the sector of laboratory animal diets has not been exempted. A disruption in supply chains due to lockdowns and travel restrictions has led to challenges in sourcing high quality feed. Additionally, due to social distancing measures and remote work policies, there have been logistical difficulties in feeding and care practices in research facilities. Consequently, the global market for laboratory animal diets has witnessed a slowdown in growth.

What Are The Diverse Applications Of These Diets?

Laboratory animal diets find their use in a range of bio-medical applications. These include but are not limited to drug discovery and development, disease research and genetic studies. Specifically tailored diets are used for animals involved in studies related to obesity, diabetes and other metabolic disorders. In such cases, apart from ensuring the nutrition of the laboratory animals, these diets also provide a controlled means to induce and maintain specific physiological conditions.

Who Are The End Users In This Market?

The end users of laboratory animal diets span across sectors such as pharmaceutical, academic institutions, contract research organizations, and government research institutes. For pharmaceutical and biotech companies, these diets constitute a significant part of their preclinical and clinical research activities. Academic institutions, on the other hand, employ these diets for teaching as well as research purposes. Ultimately, maintaining the healthy condition of laboratory animals while achieving the research objectives becomes imperative, making these end users integral to this market.